MMAC/PTEN gene expression in endometrial cancer - RT-PCR studies;Ekspresja genu MMAC/PTEN w raku endometrium - Badania RT-PCR

Przeglad Menopauzalny

Volumn 6, Issue 6, 2007, Pages 344-346

  Sobczuk, Anna ^a   Smolarz, Beata ^a   Romanowicz Makowska, Hanna ^a   Pertyński, Tomasz ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Expression; MMAC PTEN; RT PCR; Sporadic endometrial cancer

Indexed keywords

DNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RNA;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CHROMOSOME 10; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 38649123353     PISSN: 16438876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sherman M. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 2000; 13: 416-18.
2. Rose PG. Endometrial carcinoma. N Engl J Med 1996; 335: 610-9.
3. Bremond A, Bataillard A, Thomas L, et al. Cancer of the endometrium. French National Federation of Cancer (FNCLCC). Br J Cancer 2001; 84: 31-6.
4. Salvesen HB, Akslen LA. Molecular pathogenesis and prognostic factors in endometrial carcinoma. APMIS 2002; 110: 673-89.
5. Kurose K, Bando K, Fukino K, et al. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japenese endometrial cancers: evidence for inactivation of both alleles. Jpn J Cancer Res 1998; 89: 842-8.
6. Risinger JI, Hayes K, Maxwell GL, et al. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res 1998; 4: 3005-10.
7. Risinger JI, Hayes AK, Berchuck A, Barret JC. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997; 57: 4736-8.
8. Simpkins SB, Peiffer-Schneider S, Mutch DG, et al. PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors. Gynecol Oncol 1998; 71: 391-5.
9. Kinzler KW, Vogelstain B. Landscaping the cancer terrain. Science 1998; 280 1036-7.
10. Nagase S, Yamakawa H, Sato S, et al. Identification of a 790-kilobase region of common allelic loss in chromosome 10q25-q26 in human endometrial cancer. Cancer Res 1997; 57: 1630-3.
11. Levine RL, Cargile CB, Blazes MS, et al. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 1998; 58: 3254-8.
12. Maxwell GL, Risinger JI, Gumbs C, et al. Mutation of the PTEN tumor suppressor gene in endometrial hyperplaslas. Cancer Res 1998; 58: 2500-3.
13. Kappes H, Goemann C, Bamoerger AM, et al. PTEN expression in breast and endometriai cancer: correlations with steroid hormone receptor status. Pathobiology 2001; 69: 136-42.
14. Kong H, Suzuki A, Zou TT, et al. PTFN1 is frequently mutated in primary endometrial carcinomas. Nat Genet 1997; 17: 143-4.
15. Tashiro H, Blazes MS, Wu R, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997; 57: 3935-40.
16. Tashiro H, Isacson C, Levine R, et al. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 1997; 150: 177-85.
17. Whang YE, Wu X, Suzuki H, et al. Inactivation of the tumour suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 1998; 95: 5246-50.
18. Frisk T, Foukakis T, Dwight T, et al. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer. Genes Chromosomes Cancer 2002; 35: 74-80.
19. Teng DHF, Hu R, Lin H, et al. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 1997; 57: 5221-5.
20. Li DM, Sun HI. TEP1, encoded by a candidate tumor suppres sor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res 1997; 57: 2130-6.
21. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-7.